U.S. cancer death rate hits 25th year of decline
Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also are having a positive impact, experts say.
Health Care & Life Sciences
Articles
In its biggest takeover ever, Lilly buying cancer drug startup for $8 billion
Connecticut-based Loxo Oncology, which was founded in 2013 and went public a year later, has a cancer drug in development that recently received U.S. Food and Drug Administration "breakthrough therapy" status.
In one of biggest pharma deals ever, Bristol-Myers Squibb to buy biotech firm for $74B
Bristol-Myers and Celgene combined will have nine products with more than $1 billion in annual sales and significant potential for growth in the core disease areas of oncology, immunology and cardiovascular disease.
Anthem among health care stocks suffering after Obamacare ruling
While many analysts expect the ruling to be reversed by higher courts, the news adds to volatility in a sector that had barely recovered from political static this year.
Nursing homes start facing pinch of penalties for hospital readmissions
The penalties will be as much as 2 percent of Medicare reimbursements, and could be worth millions of dollars to large nursing-home chains with locations spread across Indiana and the nation.
IU Health People Mover train to shut down indefinitely
The health system said the 15-year-old elevated train service needs major maintenance, but did not say whether the system would ever return to service.
Entrepreneur finds financial success with deep-tissue therapy
Entrepreneur Michael Arnolt teamed with an inventor more than 20 years ago to launch an enterprise that has sold thousands of steel therapy instruments and trained thousands of clinicians.
After years of effort, 16 Tech innovation district finally starting construction
Developers of 16 Tech—a consortium of offices, laboratories, housing and retail space—believe the campus will become a powerful economic engine by fostering collaboration and innovation.
Trump Medicare plan targets drugs from Eli Lilly, others
Makers of antidepressants and antipsychotics like Indianapolis-based Eli Lilly and Co., AstraZeneca, Pfizer, Allergan, Bausch Health and Otsuka Holdings might face new challenges and may be deterred from price hikes.
Riley Children’s Foundation announces $175 million campaign
It’s the foundation’s first capital campaign since 2010, when it raised $200 million. The money will be used for pediatric research, patient care, maternity and newborn health, and family support programs.
FDA plans overhaul of medical device approval system
The decades-old system has long been criticized by experts for failing to catch problems with risky implants and medical instruments.
Opioid war rages on, but those on the front lines see progress
The crisis has been years in the making, and the job of wrestling it to the ground has grown into a massive task. No one is yet predicting when the state will be able to declare victory.
Americans, Canadians warned not to eat romaine lettuce
FDA Commissioner Scott Gottlieb said the FDA wanted to issue a warning about a new E. coli outbreak before people gathered for Thanksgiving meals, where the potential for exposure could increase.
FDA to crack down on menthol cigarettes, flavored vapes
The move represents a major step to further push down U.S. smoking rates, which have been falling for decades.
Insurance stalwart might be on sale block
Trucking insurer Protective Insurance Corp., long known as Baldwin & Lyons, has skidded into red ink and now is pursuing “potential strategic partnerships or transactions.“
Two IU researchers win $2.3M grant to study neuropathy in cancer patients
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
Lilly raises guidance after topping profit, revenue expectations
Lilly’s revenue in the United States rose 11 percent year-over-year, to $3.4 billion, thanks largely to rising sales of diabetes drugs Trulicity and Basgalar, cancer treatment Verzenio and psoriasis medication Taltz.
Eli Lilly partner urges investors to look beyond biotech turmoil
Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.
Disease-diagnostics firm plans to invest $5.3M, hire up to 31 workers
MiraVista Diagnostics, which processes more than 100,000 fungal-infection tests annually, plans to double the size of its headquarters near Indianapolis International Airport.
Obamacare markets stabilize, but premiums remain high for many
On average, the premium for typical plans in the 39 states that use the federal healthcare.gov website will drop 1.5 percent.